Genenta Science
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch GNTA and buy or sell other stocks, ETFs, and their options commission-free!About GNTA
Genenta Science SpA is an early-stage company, which engages in the development of first-in-class cell and gene cancer therapies. Its lead product candidate, Temferon, was developed using its platform and carries an interferon-alpha payload.
CEOPierluigi Paracchi
CEOPierluigi Paracchi
Employees13
Employees13
HeadquartersMilan, Milan
HeadquartersMilan, Milan
Founded2014
Founded2014
Employees13
Employees13
GNTA Key Statistics
Market cap25.27M
Market cap25.27M
Price-Earnings ratio-2.78
Price-Earnings ratio-2.78
Dividend yield—
Dividend yield—
Average volume97.06K
Average volume97.06K
High today$1.43
High today$1.43
Low today$1.30
Low today$1.30
Open price$1.36
Open price$1.36
Volume95.97K
Volume95.97K
52 Week high$10.00
52 Week high$10.00
52 Week low$1.30
52 Week low$1.30
Stock Snapshot
The current Genenta Science(GNTA) stock price is $1.32, with a market capitalization of 25.27M. The stock trades at a price-to-earnings (P/E) ratio of -2.78.
On 2025-12-16, Genenta Science(GNTA) stock moved within a range of $1.30 to $1.43. With shares now at $1.32, the stock is trading +1.5% above its intraday low and -7.4% below the session's peak.
Trading activity shows a volume of 95.97K, compared to an average daily volume of 97.06K.
The stock's 52-week range extends from a low of $1.30 to a high of $10.00.
The stock's 52-week range extends from a low of $1.30 to a high of $10.00.